Cargando…

Risk of Myocardial Infarction With Combination Antihypertensive Regimens Including a Dihydropyridine Calcium Channel Blocker in Hypertensive Diabetics

OBJECTIVES: The primary objective of this study was to determine if there was an increased risk of myocardial infarction (MI) in a high-risk hypertensive diabetic managed care population receiving combination antihypertensive therapy including a dihydropyridine (DHP) calcium channel blocker (CCB). M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Robert J., Alabi, Rebecca A., Kelly, William N., Diseker, Robert, Roblin, Douglas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2003
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437181/ https://www.ncbi.nlm.nih.gov/pubmed/14613359 http://dx.doi.org/10.18553/jmcp.2003.9.1.29

Ejemplares similares

How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension
por: Tocci, Giuliano, et al.
Publicado: (2017)

Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
por: Mendez, Sean R., et al.
Publicado: (2021)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Herbicidal properties of antihypertensive drugs: calcium channel blockers
por: Abdullah, Hannan Safiyyah Tan Sian Hui, et al.
Publicado: (2021)

Dihydropyridine-derived calcium channel blocker as a promising anti-hantavirus entry inhibitor
por: Wang, Bin, et al.
Publicado: (2022)

The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta
por: Takayama, Makoto, et al.
Publicado: (2009)

Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population‐Based Cohort Study
por: Rouette, Julie, et al.
Publicado: (2022)

Dihydropyridine calcium blockers do not interfere with non-rapid eye movement sleep
por: Han, GoEun, et al.
Publicado: (2022)

Quantitative Structure-Activity Relationship Studies of 4-Imidazolyl- 1,4-dihydropyridines as Calcium Channel Blockers
por: Hadizadeh, Farzin, et al.
Publicado: (2013)

A New Generation of Dihydropyridine Calcium Channel Blockers: Photostabilization of Liquid Formulations Using Nonionic Surfactants
por: Ioele, Giuseppina, et al.
Publicado: (2019)

Dihydropyridine Calcium Channel Blockers Suppress the Transcription of PD-L1 by Inhibiting the Activation of STAT1
por: Pan, Xiaohui, et al.
Publicado: (2021)

Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study
por: Ardissino, Maddalena, et al.
Publicado: (2022)

Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk
por: Haller, H
Publicado: (2008)

Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta‐analysis
por: Liang, Ling, et al.
Publicado: (2022)

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry
por: Kim, Moo Hyun, et al.
Publicado: (2023)

A(2B) adenosine receptor inhibition by the dihydropyridine calcium channel blocker nifedipine involves colonic fluid secretion
por: Asano, Teita, et al.
Publicado: (2020)

The dihydropyridine-sensitive calcium channel subtype in cone photoreceptors
Publicado: (1996)

Nonmodal gating of cardiac calcium channels as revealed by dihydropyridines
Publicado: (1989)

Internal and external effects of dihydropyridines in the calcium channel of skeletal muscle
Publicado: (1990)

Calcium-dependent inactivation of the dihydropyridine-sensitive calcium channels in GH3 cells
Publicado: (1988)

Effects of dihydropyridine calcium channel blockers on oxidized low-density lipoprotein induced proliferation and oxidative stress of vascular smooth muscle cells
por: Zou, Jun, et al.
Publicado: (2012)

Influence of pHo on calcium channel block by amlodipine, a charged dihydropyridine compound. Implications for location of the dihydropyridine receptor
Publicado: (1989)

Role of Calcium Permeation in Dihydropyridine Receptor Function: Insights into Channel Gating and Excitation–Contraction Coupling
por: Dirksen, Robert T., et al.
Publicado: (1999)

Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS
por: Toal, Corey B., et al.
Publicado: (2012)

Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium
Publicado: (1991)

Modulation of calcium channels in arterial smooth muscle cells by dihydropyridine enantiomers
Publicado: (1993)

1,4-Dihydropyridine Antihypertensive Drugs: Recent Advances in Photostabilization Strategies
por: De Luca, Michele, et al.
Publicado: (2019)

A Case of Symptomatic Myocardial Bridge Treated with Calcium Channel Blocker
por: Nemat, Arash, et al.
Publicado: (2022)

Hair analysis for beta‐blockers and calcium‐channel blockers by using liquid chromatography‐tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy
por: Taus, Francesco, et al.
Publicado: (2022)

Anticancer Effects of Antihypertensive L-Type Calcium Channel Blockers on Chemoresistant Lung Cancer Cells via Autophagy and Apoptosis
por: Wong, Bing-Sang, et al.
Publicado: (2020)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Fast activation of dihydropyridine-sensitive calcium channels of skeletal muscle. Multiple pathways of channel gating
Publicado: (1996)

Antihypertensive effects of new dihydropyridine derivatives on phenylephrine-raised blood pressure in rats
por: Fard, Sara Rowghani Haghighi, et al.
Publicado: (2016)

Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management
por: Zhou, Yi-Ting, et al.
Publicado: (2013)

Role of histopathology in the management of the gingival enlargement in a patient on antihypertensive therapy based on calcium channel blockers: a case report
por: Păunică, Stana, et al.
Publicado: (2022)

Pleiotropic Effects of Calcium Channel Blockers
por: Preston Mason, R.
Publicado: (2012)

Calcium channel blockers and Alzheimer's disease★
por: Tan, Yi, et al.
Publicado: (2012)

Discovery and Development of Calcium Channel Blockers
por: Godfraind, Théophile
Publicado: (2017)

Negative surface charge density near heart calcium channels. Relevance to block by dihydropyridines
Publicado: (1987)

A Dihydropyridine-sensitive Voltage-dependent Calcium Channel in the Sarcolemmal Membrane of Crustacean Muscle
por: Erxleben, Christian, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_3qdmebuf2e13ni5m819dv5drkd